| Company | Quest Diagnostics |
| Parent | Quest Diagnostics Incorporated |
| Ticker | DGX |
| Exchange | NYSE |
| Sector | Healthcare Services |
| S&P Rating | BB+ |
| Moody’s Rating | Ba2 |
| Investment Grade | Non-Investment Grade / High Yield |
| US Locations | 2,200+ |
| Revenue | $2.5B |
| Cap Rate Range | 5.00% – 6.00% |
| Lease Term | 10 years |
| Building Sq Ft | 3,000 – 50,000 |
Business Overview
Quest Diagnostics stands as one of the largest clinical laboratory networks in the United States, operating over 2,200 patient service centers nationwide. The company provides routine laboratory testing, drug screening, wellness services, and specialty diagnostic capabilities to healthcare providers, employers, patients, and pharmaceutical companies.
Quest’s real estate portfolio comprises patient service centers located in convenient retail and medical office settings, complemented by large reference laboratories and specialty testing facilities. The company maintains one of the broadest geographic footprints in clinical diagnostics, with significant exposure to suburban and metropolitan markets. For triple-net lease investors, Quest offers exposure to the essential diagnostic testing sector with recurring revenue from high-volume routine testing services.
Learn more on InvestmentGrade.com or explore our comprehensive NNN resources for additional healthcare tenant analysis.
Credit Rating & Investment Grade Status
Investment Grade Designation: No
Quest Diagnostics holds a BB+ rating from S&P and Ba2 from Moody’s, placing it in the speculative-grade category. The BB+ rating places Quest near the higher end of sub-investment-grade ratings, reflecting the company’s position as a major industry player with consistent cash flows, though elevated leverage from acquisitions limits investment-grade status. For rating context, see our investment-grade credit ratings guide.
Lease Structure & Terms
Quest Diagnostics typically structures 10-year triple-net leases with annual escalations of 2–3% and 3–5 renewal options at market rates. As a NNN tenant, Quest bears responsibility for property taxes, insurance, and CAM expenses across its leased properties.
Patient service center leases may include modest tenant improvements for HIPAA-compliant layouts, phlebotomy station configurations, specimen secure storage, and privacy enhancements. Laboratory facilities often require specialized electrical, plumbing, and HVAC systems, which may be funded through tenant improvement allowances.
Cap Rate & Pricing Expectations
Quest Diagnostics properties typically trade at 5.00% – 6.00% cap rates, reflecting its BB+/Ba2 speculative-grade rating and the resilient healthcare diagnostic sector dynamics. The range reflects market recognition of Quest’s scale, operational maturity, and consistent testing volumes balanced against leverage and sector-specific risks.
Cap rates vary based on property location, patient service center density, remaining lease terms, and comparable market rates. Properties in high-density suburban areas with strong demographic profiles typically trade toward lower cap rates, while secondary markets approach the upper range.
For detailed cap rate analysis, visit our investment grade guide.
Real Estate Footprint
Quest operates 2,200+ patient service centers across the United States, with particularly strong concentrations in California, Texas, Florida, New York, and the mid-Atlantic region. The company maintains a balanced portfolio across metropolitan and suburban markets with excellent geographic diversification.
Patient service center properties typically feature 3,000–8,000 square feet in accessible retail or medical office locations. Reference laboratories supporting these networks are substantially larger, ranging from 25,000 to 50,000+ square feet, with sophisticated specimen handling systems, controlled-environment capabilities, and advanced diagnostic equipment installations.
Growth Strategy & Market Position
Quest pursues selective expansion of patient service centers in growth markets while optimizing its network density in mature territories. The company invests in specialty testing capabilities and workplace wellness programs. Real estate expansion targets suburban and exurban locations serving families and employers while closing redundant facilities in saturated markets.
Pros & Cons for NNN Investors
| Pros | Cons |
|
|
Comparable Tenants
| Comparable Company | Credit Rating | Sector |
| Labcorp | BB+ / Ba1 | Healthcare Services |
| LabOne Inc. | BB– / Ba3 | Healthcare Services |
| AmeriPath (Advance Medical Optics) | BB / Ba2 | Healthcare Services |
| Sonic Healthcare Limited | BBB– / Baa3 | Healthcare Services |
Frequently Asked Questions
How does Quest Diagnostics compare to Labcorp for NNN investments?
Both Quest and Labcorp hold BB+/Ba-range ratings and operate similarly sized national networks (2,200+ and 2,000+ locations respectively). Quest carries slightly lower debt levels (Ba2 vs. Ba1), potentially providing marginally better credit stability. Both offer comparable cap rates (5.00%–6.00%) and similar lease structures. Choice between them typically depends on specific property location and investor portfolio balance.
What property specifications are typical for Quest Diagnostics leases?
Patient service centers typically occupy 3,000–8,000 square feet in retail or medical office environments with phlebotomy stations, specimen handling areas, and HIPAA-compliant privacy layouts. Reference laboratories range from 25,000–50,000+ square feet with specialized HVAC, controlled environments, and automated specimen processing capability.
How vulnerable is Quest Diagnostics to home testing disruption?
While at-home testing services (particularly COVID-19 testing and wellness kits) have grown, Quest’s core routine testing business remains resilient. Clinical lab testing requires physician orders and professional interpretation, limiting home testing’s impact on comprehensive diagnostics. However, convenience testing for routine wellness services faces competition, potentially affecting some smaller patient service centers.
What geographic markets show strongest growth for Quest facilities?
Quest prioritizes growth in suburban and exurban areas with growing populations and aging demographics. High-growth regions include suburban Texas, the Sunbelt, and mid-Atlantic areas. These markets typically support higher patient volumes and often command lower cap rates than secondary or declining markets.
Explore healthcare diagnostic NNN investments with Quest Diagnostics
InvestmentGrade.com connects investors with vetted triple-net lease opportunities featuring Quest and other major diagnostic service providers. Our team specializes in credit analysis, property valuation, and portfolio optimization for healthcare NNN investors.
Medical NNN properties deliver meaningful cost segregation value through specialized buildout components. Dialysis systems, dental operatory equipment, imaging infrastructure, laboratory casework, and medical-grade HVAC can be reclassified from 39-year to 5, 7, and 15-year recovery periods, typically representing 30% to 50% of the purchase price. See our full analysis: Medical NNN Bonus Depreciation: Dialysis, Dental, and Urgent Care Properties.
The Only Quest Diagnostics NNN Advisor Whose Fee Comes From the Deal, Not From You
In NNN buyer representation, the listing broker pays the cooperating commission. That means you get a dedicated Quest Diagnostics NNN advisor handling sourcing, underwriting, financing, and closing — and on the majority of transactions, there is no separate fee to you as the buyer.
Here’s what that buys you:
Find It — On-market and off-market Quest Diagnostics NNN properties sourced and underwritten on your behalf. We know which markets are pricing correctly, which listings are overpriced for what the lease actually says, and where the spread is worth the move.
Fund It — Acquisition financing through 150+ lender relationships: life companies, CMBS, regional banks, and credit unions that know Quest Diagnostics-grade paper. Not the first approval that comes back. The best terms on the table for this specific credit and lease structure.
Exit It — Selling a Quest Diagnostics asset or repositioning through a 1031? Our Capital Markets desk runs a quiet, targeted process. Private investors, family offices, and institutional buyers who are actively acquiring Quest Diagnostics net lease — not a public blast that signals desperation to the market.
Not committed to Quest Diagnostics? Tell us your criteria — cap rate floor, credit tier, lease structure, geography, equity check size — and we’ll find the deal that fits. We represent investors across the full NNN credit spectrum, from QSR and pharmacy to industrial, medical, and big box retail. The tenant is a variable. Your criteria is the constant.
Get Your Free Quest Diagnostics NNN Consultation →
In a 1031 exchange with a deadline? Tell us your timeline — we move faster.
Related NNN Tenants
- Ascension
- Aspen Dental
- Athletico
- BioLife Plasma
- Concentra / Humana
- Corewell Health
- CSL Plasma
- DaVita Dialysis
- EyeCare Partners
- Fresenius
- Grifols
- Henry Ford Health
- HCA Healthcare
- Heartland Dental
- Mary Washington Healthcare
- McLaren Health Care
- Oak Street Health
- Piedmont Healthcare
- Sparrow Health
- Trinity Health
- U of M Health
- University of Pittsburgh Medical Center (UPMC)
- Acadia Healthcare
- AFC Urgent Care
- ATI Physical Therapy
- CityMD / Summit Health
- Encompass Health
- Fast Pace Urgent Care
- MedExpress Urgent Care
- MyEyeDr
- NextCare Urgent Care
- Octapharma Plasma
- Pacific Dental Services
- Select Physical Therapy
- Smile Brands
- VCA Animal Hospitals
- WellNow Urgent Care
- Banfield Pet Hospital
- Labcorp
- National Vision
Own a Quest Diagnostics Property? Capital Markets Strategies Beyond Selling
Maturing debt and considering refinancing? Our capital markets team maintains 150+ lender relationships underwriting NNN properties across investment-grade and non-investment-grade credit tiers. We structure rate-and-term refinancing, cash-out refis, and bridge-to-perm takeouts.
Evaluating a 1031 exchange or disposition? We represent both sides of Quest Diagnostics NNN transactions — whether you are looking to exit at peak value, exchange into a higher-quality credit tenant, or reposition within the same sector.
Need a current valuation? We maintain live comps on Quest Diagnostics NNN transactions and can produce a Broker Opinion of Value within 48 hours reflecting today’s cap rate market.
